Jeremy W. Chambers

researcher

Born 2000-01-01

Jeremy W. Chambers is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-6143-3091
P1153Scopus author ID15724589300

P69educated atClemson UniversityQ631066
West Liberty UniversityQ7985746
P108employerFlorida International UniversityQ1065809
P734family nameChambersQ13573116
ChambersQ13573116
ChambersQ13573116
P735given nameJeremyQ1514341
JeremyQ1514341
P106occupationresearcherQ1650915
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q35562028A rapid and sensitive high-throughput screening method to identify compounds targeting protein-nucleic acids interactions.
Q34764609A small molecule bidentate-binding dual inhibitor probe of the LRRK2 and JNK kinases.
Q48774243A trivalent approach for determining in vitro toxicology: Examination of oxime K027.
Q35216733Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail.
Q38735220Analysis of Chemotherapeutic Drug Delivery at the Single Cell Level Using 3D-MSI-TOF-SIMS.
Q36931977Atmospheric oxygen inhibits growth and differentiation of marrow-derived mouse mesenchymal stem cells via a p53-dependent mechanism: implications for long-term culture expansion
Q36526237Blocking c-Jun N-terminal kinase (JNK) translocation to the mitochondria prevents 6-hydroxydopamine-induced toxicity in vitro and in vivo.
Q37380099Fluorescently labeled circular DNA molecules for DNA topology and topoisomerases.
Q33614656Glutamine metabolism is essential for human cytomegalovirus infection
Q34963377Mitochondrial c-Jun N-terminal kinase (JNK) signaling initiates physiological changes resulting in amplification of reactive oxygen species generation.
Q64965958Phosphoregulation on mitochondria: Integration of cell and organelle responses.
Q34511031Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1
Q46904542Residues in an ATP binding domain influence sugar binding in a trypanosome hexokinase
Q57461395Sab Concentrations Indicate Chemotherapeutic Susceptibility in Ovarian Cancer Cell Lines
Q50948326Sab is differentially expressed in the brain and affects neuronal activity.
Q27658377Synthesis, Biological Evaluation, X-ray Structure, and Pharmacokinetics of Aminopyrimidine c-jun-N-terminal Kinase (JNK) Inhibitors
Q46762680The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1.
Q90232049Tyrosyl-DNA Phosphodiesterase 1 and Topoisomerase I Activities as Predictive Indicators for Glioblastoma Susceptibility to Genotoxic Agents

Search more.